Consultation Services
Drug Discovery and Development Solutions
Providing Everything You Need . . .
The Role That’s Missing in Life Sciences
A translator between science, strategy, and capital.
-
Not a consultant.
-
Not a BD person.
-
Not a CSO.
But someone who ensures that:
-
The science is credible
-
The story is investable
-
The evidence plan is realistic
-
The risks are transparent
-
The valuation is defensible
When this role is missing, boards and investors face the same problem: progress is visible, but decision accountability is not.
Why Investors Struggle With Early-Stage Biotech
Early-stage biotech doesn’t suffer from lack of intelligence.
It suffers from misaligned perspectives
-
Founders explain the science.
-
Investors assess decision risk.
-
Pharma looks for value under uncertainty.
These three conversations rarely meet.
The result
-
Impressive decks
-
Long diligences
-
Delayed decisions
-
Late surprises
The biggest value is aligning on what is actually blocking a decision.
The evaluation framework
-
Strong biology → weak articulation
-
Interesting data → unclear evidence sequence
-
Optimism → misaligned expectations
-
Hope → stalled decisions
They fail not because science is weak but because no one ever aligned on what must be true for it to matter.
When we evaluate we look at 5 dimensions
-
Science validity – reproducible, differentiated, biologically grounded
-
Developability – CMC feasibility and scalability early, not later
-
Clinical logic – indication, endpoints, comparator, PoC path
-
Regulatory viability – achievable sequence, not theoretical approval
-
Value & access – evidence that translates into payer and partner value
Together, not sequentially
When these five are aligned, decisions accelerate.
When they aren’t, no amount of enthusiasm fixes it.
How we can help you…
-
You bring the science. We strengthen investor confidence, support funding strategy, and improve visibility with the right strategic and co-development partners.
​​
-
You focus on innovation. We manage the regulatory logic and scientific trade-offs that come with moving fast.
Investor-Ready Funding Launchpad
-
Decode investor expectations & craft compelling pitch decks
-
Prepare Investor narratives
-
Open doors to funding sources
-
Connect you to our network of investors (Indian and Global: VCs, angel investors, and foundation funders)
-
Guide you through govt. grants and scheme, money that's easier to access than VC
-
Realistic portfolio assessment: fundable now or pivot?
Scientific Support & Development Planning
-
Start-to-end guidance from drug discovery till development
-
Creating a blueprint with a decision tree for every milestone to help you make crucial decisions
-
Phased roadmap from discovery → lead optimization → IND-enabling studies → clinical trials
-
Regulatory readiness gaps ​
-
Clinical phase timelines, costs & de-risking strategies​
-
Build your regulatory & scientific network
-
Scientific writing, grant writing, and submissions
-
Due diligence for investors (VCs, Govt. agencies, Trusts), founders
Strategic Planning l Decisive Leadership l Innovation
We bring together a single, coordinated model to reduce complexity, accelerate timelines, and deliver decision-ready data that moves programs forward with confidence.
_edited.jpg)
Flexible Business Models: Your Trusted Partner
​
Flexible engagement, capital efficiency, and integrated expertise to accelerate IND enabling
Engagement Models Tailored to Your Needs:
​
-
Fee-for-Service, Project-based consulting
-
Retainer Model with dedicated team allocation
-
Risk-Sharing Partnership with Success-based fees
-
Equity Partnership with Strategic Investment
-
Hybrid Models with Customized Combinations
-
Premium yet cost-effective mid-tier.
-
Integrated commercialization strategy
Why Clients Trust Abhinavayan
​
-
Transparent Communication: Regular updates
-
Proven Methodology
-
Confidentiality Assurance with NDA
-
Quality Commitment
-
Long-term Partnership Building relationships
-
Balanced cost and quality
-
Investor networking and funding advisory
Client Success Stories:
85%
Clients re-engage
for multiple projects
within a year
~50%
Average cost savings
compared to traditional CRO models
95%
Client satisfaction
with on-time,
on-budget delivery
0
Conflicts,
IP disputes or confidentiality breaches
Guiding Your Program from Target Ideation to the Clinic
Integrating biology, data, and strategic criteria to prioritize translational targets
-
We deliver end-to-end solutions from target validation till clinical stage, backed by a strategic project blueprint that outlines every phase, empowering confident and data-driven Go/No-Go decisions with risk register.
​
-
Rescue/realignment of “stuck” discovery or preclinical programs (scientific gap analysis, data package upgrade, decision tree).
Project blue print includes:
​
-
Define project scope, objectives, timelines & resources
-
Preliminary validation plan
-
Defined Go/No-Go criteria for full blown target
-
Proof-of-concept milestones
-
Desired target product profile (TPP)
-
Screening cascade for hit and lead Id, profilation studies for lead
-
Defined Go/No-Go criteria for candidate selection
Regulatory Success Partner
End-to-end regulatory guidance from preclinical safety to clinical approval
Contact Our Experts
Abhinavayan’s consultation services focus on clarity and control across the development lifecycle. We work with teams to sharpen scientific strategy, anticipate regulatory expectations, and structure programs that are realistic, fundable, and milestone-driven, reducing technical risk while improving investor and partner confidence.